• Return to Headlines

Vertex Pharm Looks to Continue to Trade Above its Annual-High Share Price Today

By James Quinn

Vertex Pharm (NASDAQ:VRTX) traded today at a new 52-week high of $178.86. So far today approximately 97,000 shares have been exchanged, as compared to an average 30-day volume of 1.9 million shares.

There is potential upside of 7.3% for shares of Vertex Pharm based on a current price of $178.51 and an average consensus analyst price target of $191.59. Vertex Pharm shares have support at the 50-day moving average (MA) of $156.40 and additional support at the 200-day MA of $155.97.

Vertex Pharm share prices have moved between a 52-week high of $178.86 and a 52-week low of $127.67 and are now trading 40% above that low price at $178.51 per share. The 200-day and 50-day moving averages have moved 0.31% higher and 1.06% higher over the past week, respectively.

Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes pharmaceutical products. The Company develops drugs for the treatment of cystic fibrosis, cancer, inflammatory bowel, autoimmune disease, and neurological disorders. Vertex Pharmaceuticals serves the healthcare sector internationally.

SmarTrend is monitoring the recent change of momentum in Vertex Pharm. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Vertex Pharm in search of a potential trend change.

Keywords: 52 week high/lows vertex pharm

Ticker(s): VRTX